Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Brill-Symmers Disease

triethylenemelamine has been researched along with Brill-Symmers Disease in 3 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RIEGEL, R2
KRUCKEMEYER, K2
MOLANDER, DW1

Other Studies

3 other studies available for triethylenemelamine and Brill-Symmers Disease

ArticleYear
[Injury to the hematopoietic system after treatment with triethylene iminotriazine (TEM) in a case of Brill-Symmers disease].
    Deutsches medizinisches Journal, 1954, Apr-15, Volume: 5, Issue:8

    Topics: Hematopoietic System; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Triethylenemelamine

1954
[Comparative studies on the effects of triethylene melamine and x-rays on giant follicular lymphoblastoma (Brill-Symmers' disease)].
    Deutsches medizinisches Journal, 1955, Aug-15, Volume: 6, Issue:15-16

    Topics: Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Triethylenemelamine; X-Rays

1955
THE MALIGNANT LYMPHOMAS.
    The American journal of nursing, 1963, Volume: 63

    Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma

1963